The anatomy of a US preventive services task force recommendation: Lipid screening for children and adolescents

David C. Grossman, Virginia A. Moyer, Bernadette M. Melnyk, Roger Chou, Thomas G. DeWitt

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Differing methods for guideline development result in conflicting recommendations and clinical practice variation. This article details the approach used by the US Preventive Services Task Force to issue recommendation statements, using the 2007 recommendation for screening of lipid levels as an example. An analytic framework served as the source of key questions for a systematic review of the evidence on lipid screening in children and adolescents. Evidence was insufficient, of poor quality, or conflicting to answer 7 of the 10 questions. There was no direct evidence of the benefit of lipid screening, and insufficient evidence existed in the indirect chain of evidence to support a recommendation. In 2008, the American Academy of Pediatrics issued a clinical policy statement recommending screening for targeted children. We discuss the contrasting approach to the development of this guideline. The use of a standardized method to develop clinical guidelines promotes trust and credibility among patients and clinicians.

Original languageEnglish (US)
Pages (from-to)205-210
Number of pages6
JournalArchives of Pediatrics and Adolescent Medicine
Volume165
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Advisory Committees
Anatomy
Guidelines
Lipids
Pediatrics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The anatomy of a US preventive services task force recommendation : Lipid screening for children and adolescents. / Grossman, David C.; Moyer, Virginia A.; Melnyk, Bernadette M.; Chou, Roger; DeWitt, Thomas G.

In: Archives of Pediatrics and Adolescent Medicine, Vol. 165, No. 3, 03.2011, p. 205-210.

Research output: Contribution to journalArticle

Grossman, David C. ; Moyer, Virginia A. ; Melnyk, Bernadette M. ; Chou, Roger ; DeWitt, Thomas G. / The anatomy of a US preventive services task force recommendation : Lipid screening for children and adolescents. In: Archives of Pediatrics and Adolescent Medicine. 2011 ; Vol. 165, No. 3. pp. 205-210.
@article{1fe29a93ea57468e8985967b06759943,
title = "The anatomy of a US preventive services task force recommendation: Lipid screening for children and adolescents",
abstract = "Differing methods for guideline development result in conflicting recommendations and clinical practice variation. This article details the approach used by the US Preventive Services Task Force to issue recommendation statements, using the 2007 recommendation for screening of lipid levels as an example. An analytic framework served as the source of key questions for a systematic review of the evidence on lipid screening in children and adolescents. Evidence was insufficient, of poor quality, or conflicting to answer 7 of the 10 questions. There was no direct evidence of the benefit of lipid screening, and insufficient evidence existed in the indirect chain of evidence to support a recommendation. In 2008, the American Academy of Pediatrics issued a clinical policy statement recommending screening for targeted children. We discuss the contrasting approach to the development of this guideline. The use of a standardized method to develop clinical guidelines promotes trust and credibility among patients and clinicians.",
author = "Grossman, {David C.} and Moyer, {Virginia A.} and Melnyk, {Bernadette M.} and Roger Chou and DeWitt, {Thomas G.}",
year = "2011",
month = "3",
doi = "10.1001/archpediatrics.2010.299",
language = "English (US)",
volume = "165",
pages = "205--210",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - The anatomy of a US preventive services task force recommendation

T2 - Lipid screening for children and adolescents

AU - Grossman, David C.

AU - Moyer, Virginia A.

AU - Melnyk, Bernadette M.

AU - Chou, Roger

AU - DeWitt, Thomas G.

PY - 2011/3

Y1 - 2011/3

N2 - Differing methods for guideline development result in conflicting recommendations and clinical practice variation. This article details the approach used by the US Preventive Services Task Force to issue recommendation statements, using the 2007 recommendation for screening of lipid levels as an example. An analytic framework served as the source of key questions for a systematic review of the evidence on lipid screening in children and adolescents. Evidence was insufficient, of poor quality, or conflicting to answer 7 of the 10 questions. There was no direct evidence of the benefit of lipid screening, and insufficient evidence existed in the indirect chain of evidence to support a recommendation. In 2008, the American Academy of Pediatrics issued a clinical policy statement recommending screening for targeted children. We discuss the contrasting approach to the development of this guideline. The use of a standardized method to develop clinical guidelines promotes trust and credibility among patients and clinicians.

AB - Differing methods for guideline development result in conflicting recommendations and clinical practice variation. This article details the approach used by the US Preventive Services Task Force to issue recommendation statements, using the 2007 recommendation for screening of lipid levels as an example. An analytic framework served as the source of key questions for a systematic review of the evidence on lipid screening in children and adolescents. Evidence was insufficient, of poor quality, or conflicting to answer 7 of the 10 questions. There was no direct evidence of the benefit of lipid screening, and insufficient evidence existed in the indirect chain of evidence to support a recommendation. In 2008, the American Academy of Pediatrics issued a clinical policy statement recommending screening for targeted children. We discuss the contrasting approach to the development of this guideline. The use of a standardized method to develop clinical guidelines promotes trust and credibility among patients and clinicians.

UR - http://www.scopus.com/inward/record.url?scp=79952321946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952321946&partnerID=8YFLogxK

U2 - 10.1001/archpediatrics.2010.299

DO - 10.1001/archpediatrics.2010.299

M3 - Article

C2 - 21383269

AN - SCOPUS:79952321946

VL - 165

SP - 205

EP - 210

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 3

ER -